LAUSR

Obsessive–compulsive disorder (OCD) is a common psychiatric disorder that affects approximately 1–3% of the general population. It is characterized by disabling obsessions (intrusive unwanted thoughts) and/or compulsions (ritualized repetitive behaviors). Catechol-O-methyltransferase (COMT) enzyme has an important role in inactivation of dopamine and higher dopamine levels may be implicated in OCD, hence COMT gene is a suitable candidate for OCD. Several case-control studies have evaluated the role of COMT Val 158Met (rs4680;472G- > A) polymorphism as a risk factor for OCD but the results remained inconclusive, hence present meta-analysis was designed to find out correct assessment. All studies that investigated the association of COMT gene Val158Met polymorphism with OCD risk, were considered in the present meta-analysis. Statistical analysis was performed with the software program MetaAnalyst. In the current meta-analysis, 14 case-control studies with 1435 OCD cases and 2753 healthy controls were included. The results indicated significant association between COMT Val158Met polymorphism and OCD risk using allele contrast, homozygote and dominant models (OR A vs G  = 1.14; 95% CI = 1.02–1.27; p  = 0.01; OR AAvs.GG  = 1.33; 95% CI = 1.09–1.62, p  = 0.004; OR AA + AGvs.GG  = 1.14; 95% CI = 1.0–1.32; p  = 0.04). In subgroup analysis based on case gender, meta-analysis of male cases showed significant association using all five genetic models (OR AAvsGG  = 1.99; 95%CI = 1.42–2.59; p = <0.001; OR AA + AGvs.GG  = 1.59; 95% CI = 1.20–2.10; p  = 0.001), but did not show any association between COMT Val 158Met polymorphism and OCD risk in females. In conclusion, results of present meta-analysis supports that the COMT Val158Met polymorphism is a risk factor for OCD especially for males.